Hodgkin and non-Hodgkin lymphoma: What's the difference?

Learn about the key differences between these distinct diseases with similar names.

scientist looking through microscope

Updated on October 11, 2024.

Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) are blood cancers that develop in the lymphatic system. They occur when lymphocytes start to grow abnormally and develop into lymphomas. Lymphocytes are types of white blood cells in the immune system that help protect the body from infection and disease.

Key differences

Although these illnesses share similar names and are both blood cancers, it is important to understand that they are two distinct diseases. The main difference between HL and NHL is the composition of the cells that indicate the disease. When viewed under a microscope, if a specific type of abnormal cell called a Reed-Sternberg cell is detected, it indicates HL. If a Reed-Sternberg cell is not present, it signals NHL.

"Hodgkin's lymphoma doesn't spread via the blood system, rather it spreads lymph node to lymph node in an orderly fashion," explains Owen O'Connor, MD, PhD, an oncologist and American Cancer Society Research Professor based in White Plains, New York. "It is treated with a classic chemotherapy regimen, which cures about 70 percent of all cases."

Non-Hodgkin's lymphoma, on the other hand, is not a single disease. Rather, it's a group of related cancers that can spread via blood or the lymphatic system. Non-Hodgkin lymphomas are divided into two major groups:

  • B-cell lymphomas develop from abnormal B-lymphocytes and account for the majority of NHL cases—approximately 85 percent. 
  • T-cell lymphomas make up the remaining 15 percent of cases. They develop from abnormal T-lymphocytes. 

There are more than 70 different types of NHL, called subtypes. While these subtypes share common characteristics, they: 

  • Look different when viewed with a microscope
  • Have different molecular features
  • Grow in different ways
  • Affect the body in different ways

They also require different approaches to treatment. This usually includes some form of chemotherapy, radiation, or biologic therapy, or a combination of different therapies. “The treatment is tailored to the specific type and aggressiveness that you have,” explains Dr. O'Connor.

Signs and symptoms

As these are diseases of cells that play a role in our immune systems, symptoms are not lymphoma-specific and are similar to those of other illnesses. Common symptoms include:

  • Enlarged lymph nodes, which may be causing pain, but may also be painless
  • Weight loss without an explanation
  • Fever, chills, sweating, and/or night sweats
  • Fatigue
  • Itching

As these symptoms are common for other illnesses, most people who have these complaints will not have lymphoma. However, if you have persistent symptoms, it is important that you visit your healthcare provider for an examination.

Who is at risk?

Though the causes remain unknown, the risk may be higher in individuals who:

  • Have a family history
  • Are affected with an autoimmune disease
  • Have a weakened immune system
  • Have been exposed to chemicals such as pesticides, fertilizers, or organic solvents for a long period
  • Have been infected with viruses such as Epstein-Barr, human T-lymphotropic virus type 1 (HTLV-1), HIV/AIDS, or hepatitis C

The risk is also for higher for people who have been infected with certain bacteria, such as H-pylori.

Article sources open article sources

American Cancer Society. What Is Non-Hodgkin Lymphoma? Revised February 15, 2024.
American Cancer Society. Hodgkin Lymphoma. Accessed October 11, 2024.
National Cancer Institute: Reed-Sternberg cell. Accessed October 11, 2024.
American Cancer Society. What Is Hodgkin Lymphoma? Revised May 1, 2018.
Lymphoma Research Foundation. What is Lymphoma? Accessed October 11, 2024.
Lymphoma Research Foundation. Understanding Lymphoma. Accessed October 11, 2024.
American Cancer Society. Non-Hodgkin Lymphoma Risk Factors. Revised February 15, 2024.
The George Washington University Hospital. Non-Hodgkin’s Lymphomas. Accessed October 11, 2024.

More On

One-to-one: metastatic breast cancer

video

One-to-one: metastatic breast cancer
Ryland J. Gore, MD, MPH, FACS, explains the impact of racial disparities when it comes to metastatic breast cancer.
Low-grade serous ovarian cancer: Coping with a rare cancer

article

Low-grade serous ovarian cancer: Coping with a rare cancer
Where to find information, support, and healthcare providers who specialize in the treatment of this rare gynecologic cancer.
9 cancer signs you shouldn't ignore

slideshow

9 cancer signs you shouldn't ignore
Subtle changes could signal something serious, like breast, colon, or lung cancer.
Life Unscripted: 5 questions with Angel about early breast cancer

video

Life Unscripted: 5 questions with Angel about early breast cancer
Angel shares her journey and offers valuable perspectives on living with early breast cancer.
Is cancer hereditary?

video

Is cancer hereditary?
Tonya Echols Cole, MD, delves into the key factors that contribute to the development of cancer.